| Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy A Heczey, D Liu, G Tian, AN Courtney, J Wei, E Marinova, X Gao, L Guo, ... Blood, The Journal of the American Society of Hematology 124 (18), 2824-2833, 2014 | 290 | 2014 |
| CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo G Tian, AN Courtney, B Jena, A Heczey, D Liu, E Marinova, L Guo, X Xu, ... The Journal of clinical investigation 126 (6), 2341-2355, 2016 | 156 | 2016 |
| Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China J Wang, Y Liu, CL Zhang, BY Ji, LZ Zhang, YZ Shao, SL Jiang, Y Suzuki, ... Journal of clinical microbiology 49 (4), 1354-1362, 2011 | 110 | 2011 |
| Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system X Xu, WAH Hegazy, L Guo, X Gao, AN Courtney, S Kurbanov, D Liu, ... Cancer research 74 (21), 6260-6270, 2014 | 78 | 2014 |
| Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells D Liu, L Song, VS Brawley, N Robison, J Wei, X Gao, G Tian, A Margol, ... Clinical immunology 149 (1), 55-64, 2013 | 67 | 2013 |
| Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature Medicine 29 (6), 1379-1388, 2023 | 58 | 2023 |
| IL-21 selectively protects CD62L+ NKT cells and enhances their effector functions for adoptive immunotherapy H Ngai, G Tian, AN Courtney, SB Ravari, L Guo, B Liu, J Jin, ET Shen, ... The Journal of Immunology 201 (7), 2141-2153, 2018 | 45 | 2018 |
| Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy AN Courtney, G Tian, LS Metelitsa Blood 141 (8), 869-876, 2023 | 24 | 2023 |
| LEF1 drives a central memory program and supports antitumor activity of natural killer T cells H Ngai, GA Barragan, G Tian, JC Balzeau, C Zhang, AN Courtney, L Guo, ... Cancer immunology research 11 (2), 171-183, 2023 | 11 | 2023 |
| Cross-talk between NKT cells and tumor associated macrophages in the tumor microenvironment AN Courtney, G Tian, D Liu, E Marinova, A Heczey, X Xu, L Guo, X Gao, ... The Journal of Immunology 196 (1_Supplement), 142.7-142.7, 2016 | 10 | 2016 |
| NKT cells control tumor associated macrophages and metastatic growth in neuroblastoma AN Courtney, G Tian, E Marinova, J Wei, L Guo, J Jin, X Gao, ... The Journal of Immunology 198 (1_Supplement), 204.24-204.24, 2017 | 7 | 2017 |
| Development of an effective cancer vaccine using attenuated Salmonella and type iii secretion system to deliver recombinant tumor-associated antigens X Xu, WAH Hegazy, L Guo, X Gao, AN Courtney, S Kurbanov, D Liu, ... Cancer research 74 (21), 6260, 2014 | 4 | 2014 |
| NKT cells as a novel platform for cancer immunotherapy with chimeric antigen receptors A Heczey, D Liu, A Courtney, E Marinova, G Tian, E Yvon, J Wei, G Dotti, ... Molecular Therapy 21, S5-S5, 2013 | 4 | 2013 |
| Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma JA Tomolonis, X Xu, KH Dholakia, C Zhang, L Guo, AN Courtney, S Wang, ... Journal for Immunotherapy of Cancer 11 (3), 2023 | 3 | 2023 |
| Solid pseudopapillary tumor of pancreas: A case report and review of genetic features. G Tian, VH Savell, JM Esquilin Pediatric Blood & Cancer 65 (6), e26980-e26980, 2018 | 3 | 2018 |
| Refining chimeric antigen receptors via barcoded protein domain combination pooled screening X Rios, O Pardias, MA Morales, P Bhattacharya, Y Chen, L Guo, C Zhang, ... Molecular Therapy 31 (11), 3210-3224, 2023 | 2 | 2023 |
| Abstract IA09: harnessing natural and engineered properties of NKT cells for cancer immunotherapy A Heczey, AN Courtney, H Ngai, G Tian, SN Robinson, G Dotti, ... Cancer Immunology Research 7 (2_Supplement), IA09-IA09, 2019 | 2 | 2019 |
| HARNESSING CRISPR/CAS9 MUTAGENESIS SCREENING FOR RATIONAL DESIGN OF NEXT-GENERATION CAR-NKT THERAPY AGAINST NEUROBLASTOMA G Tian, X Rios, C Zhang, J Drabek, C Amador, L Metelitsa PEDIATRIC BLOOD & CANCER 69, S229-S229, 2022 | 1 | 2022 |
| CD62L+ NKT cells have superior in vivo persistence and anti-tumor activity G Tian, AN Courtney, B Jena, A Heczey, D Liu, E Marinova, L Guo, X Xu, ... The Journal of Immunology 196 (1_Supplement), 142.1-142.1, 2016 | 1 | 2016 |
| Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature medicine 30 (4), 1210, 2024 | | 2024 |
